 |
|  |
Jan-02-19 | Upgrade |
Morgan Stanley |
Underweight → Overweight |
|
|
Jan-02-19 | Upgrade |
Citigroup |
Neutral → Buy |
|
|
Nov-02-18 | Upgrade |
Argus |
Hold → Buy |
|
|
Oct-16-18 | Initiated |
Barclays |
Underweight |
$73 |
|
May-17-18 | Resumed |
Piper Jaffray |
Overweight |
$77 |
|
Feb-06-18 | Reiterated |
Citigroup |
Neutral |
$66 → $70 |
|
Jan-03-18 | Upgrade |
Raymond James |
Mkt Perform → Outperform |
|
|
Jan-03-18 | Initiated |
Evercore ISI |
Outperform |
|
|
Jan-02-18 | Upgrade |
JP Morgan |
Neutral → Overweight |
|
|
Jan-02-18 | Upgrade |
BofA/Merrill |
Neutral → Buy |
|
|
Aug-17-17 | Initiated |
Citigroup |
Neutral |
$63 |
|
Jul-28-17 | Reiterated |
UBS |
Neutral |
$57 → $62 |
|
Jul-27-17 | Reiterated |
Barclays |
Overweight |
$64 → $70 |
|
Jun-30-17 | Initiated |
Cantor Fitzgerald |
Overweight |
$70 |
|
Apr-27-17 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$55 → $58 |
|
Apr-04-17 | Upgrade |
Leerink Partners |
Mkt Perform → Outperform |
|
|
Oct-26-16 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$50 → $55 |
|
Oct-13-16 | Initiated |
Wells Fargo |
Outperform |
|
|
Jul-27-16 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$47 → $50 |
|
Jun-06-16 | Resumed |
JP Morgan |
Neutral |
|
|
|
 |
Feb-16-19 08:40AM | Does Baxter International Inc. (NYSE:BAX) Have A Good P/E Ratio? Simply Wall St. |
Feb-14-19 09:07AM | Baxter's Acute Therapies Profile Strong, Competition Rife Zacks |
Feb-13-19 04:15PM | Baxter to Present at the Barclays Global Healthcare Conference Business Wire |
Feb-11-19 08:00AM | Baxter and NantHealth® Advance Digital Health Technology for Medical Devices in the Hospital ICU Business Wire |
Feb-06-19 04:15PM | Baxter to Present at the Raymond James 40th Annual Institutional Investors Conference Business Wire |
Feb-05-19 01:21PM | Affiliate of Charlotte-based Premier partners with Baxter to make generic drugs more available American City Business Journals |
Feb-04-19 07:47PM | [$$] Blood-Pressure Medicine Will Be First Product for New Generic Drug Venture The Wall Street Journal |
06:02PM | [$$] Blood-Pressure Medicine Will Be First Product for New Generic Drug Venture The Wall Street Journal |
07:25AM | Report: Developing Opportunities within Ensco plc, Third Point Reinsurance, Baxter International, Ultrapar Participacoes S.A, Endeavour Silver, and Ingles Markets Future Expectations, Projections Moving into 2019 GlobeNewswire |
Feb-01-19 09:20AM | Edited Transcript of BAX earnings conference call or presentation 31-Jan-19 1:30pm GMT Thomson Reuters StreetEvents |
Jan-31-19 05:53PM | Baxter (BAX) Q4 2018 Earnings Conference Call Transcript Motley Fool |
11:42AM | Baxter's (BAX) Earnings, Revenues Beat Estimates in Q4 Zacks |
08:40AM | Baxter International (BAX) Q4 Earnings and Revenues Surpass Estimates Zacks |
08:24AM | Baxter: 4Q Earnings Snapshot Associated Press |
07:15AM | Baxter Reports 2018 Fourth-Quarter and Full-Year Results Business Wire |
06:21AM | Before Investing In Baxter International Inc. (NYSE:BAX), Consider This Simply Wall St. |
Jan-30-19 01:44PM | Health care giant Baxter to grow Glendale company's medical software American City Business Journals |
09:02AM | Medical Products' Earnings Lineup for Jan 31: EW, BAX & More Zacks |
Jan-29-19 06:01PM | Baxter to Present at the 8th Annual SVB Leerink Global Healthcare Conference Business Wire |
Jan-28-19 07:55AM | Can BD Medical Drive Becton, Dickinson's (BDX) Q1 Earnings? Zacks |
Jan-24-19 06:02PM | Investors With Outsized Bets on One Stock: David Tepper and Daniel Loeb GuruFocus.com |
10:31AM | Baxter International (BAX) Reports Next Week: Wall Street Expects Earnings Growth Zacks |
09:56AM | Will Core Renal Care Unit Fuel Baxter's (BAX) Q4 Earnings? Zacks |
Jan-21-19 07:56AM | Will Core MedSurg Segment Aid Stryker's (SYK) Q4 Earnings? Zacks |
Jan-18-19 09:44AM | Stock Market News For Jan 18, 2019 Zacks |
08:02AM | Baxter (BAX) Gains From Sharesource's Global Success Rates Zacks |
Jan-17-19 08:43PM | [$$] The shifting fortunes of art fairs Financial Times |
08:30AM | Baxter Announces 5 Million Home Dialysis Treatments Managed Globally with Sharesource Remote Patient Management Business Wire |
06:06AM | A Look At The Intrinsic Value Of Baxter International Inc. (NYSE:BAX) Simply Wall St. |
Jan-15-19 08:56AM | Will Instruments Fuel Intuitive Surgical (ISRG) Q4 Earnings? Zacks |
06:09AM | Varian Medical (VAR) to Report Q1 Earnings: What's in Store? Zacks |
Jan-08-19 09:58AM | Stock Market News For Jan 8, 2019 Zacks |
07:21AM | Baxter's PD Solution to Treat Patients, Prospects Bright Zacks |
Jan-07-19 08:40AM | Baxter Starts U.S. Clinical Trial for on-Demand Peritoneal Dialysis Solution System Business Wire |
Jan-03-19 10:10AM | Can Baxter (BAX) Keep the Earnings Surprise Streak Alive? Zacks |
Jan-02-19 02:34PM | Morgan Stanley Finds A Few Reasons To Double Upgrade Baxter Benzinga |
06:04AM | Read This Before Buying Baxter International Inc. (NYSE:BAX) For Its Dividend Simply Wall St. |
Dec-31-18 03:11PM | 6 Undervalued Stocks Growing Earnings GuruFocus.com |
Dec-24-18 09:29AM | Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III Zacks |
Dec-21-18 04:15PM | Baxter to Host Fourth Quarter 2018 Financial Results Conference Call for Investors Business Wire |
Dec-20-18 09:27AM | 4 Stocks Respected Activist Investor Jeffrey Smith Bought in Q3 (and 1 He Dumped) Insider Monkey |
07:20AM | New Research: Key Drivers of Growth for Baxter International, Sempra Energy, Nielsen Holdings Plc, ARRIS International plc, Ionis Pharmaceuticals, and KB Home Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire |
Dec-19-18 02:46PM | Credit Suisse Initiates Coverage of Large Health Care Stocks GuruFocus.com |
09:30AM | Stock Market News For Dec 19, 2018 Zacks |
Dec-18-18 08:30AM | Baxter Launches Curved Applicator for Floseal, Expanding Use of Leading Hemostat During ENT Procedures Business Wire |
Dec-16-18 08:35AM | At US$65.70, Is It Time To Put Baxter International Inc. (NYSE:BAX) On Your Watch List? Simply Wall St. |
Dec-13-18 09:04AM | Here's Why You Should Hold Baxter International (BAX) Now Zacks |
Dec-10-18 08:45AM | Baxter & EFCNI Collaborate to Improve Care for Preterm Born Zacks |
Dec-08-18 10:20AM | Hedge Funds Are Still Crazy About Baxter International Inc. (BAX) Insider Monkey |
Dec-06-18 05:32PM | Dan Loeb Sells Baxter International Shares at Strong Gain GuruFocus.com |
04:30PM | Baxter Supports New EFCNI Standards in Newborn Care in Raising Awareness of Risks from Malnutrition Business Wire |
08:15AM | Baxter Appoints Patricia Morrison and Amy Wendell to Its Board Business Wire |
Dec-04-18 04:15PM | Baxter to Present at the 37th Annual J.P. Morgan Healthcare Conference Business Wire |
Dec-01-18 08:18AM | Baxter International Inc (NYSE:BAX): Has Recent Earnings Growth Beaten Long-Term Trend? Simply Wall St. |
Nov-28-18 04:32PM | MS Global Franchise Fund's Top 5 Buys in 3rd Quarter GuruFocus.com |
Nov-15-18 10:02AM | Baxter (BAX) Launches Peri-Strips & Tisseel Prima, Shares Up Zacks |
Nov-14-18 08:15AM | Baxter Unveils New Products at the ASMBS Obesity Week Meeting to Help Surgeons Overcome Challenges During Bariatric Surgery Business Wire |
Nov-13-18 09:21AM | Baxter board approves $2 billion increase to share buyback authorization MarketWatch |
09:15AM | Baxter Declares Quarterly Dividend and Announces Expanded Share Repurchase Authorization Business Wire |
08:15AM | Baxter Highlights Data at ISPOR Europe 2018 on Clinical and Economic Benefits When Addressing Malnutrition, Intraoperative Bleeding Business Wire |
Nov-12-18 09:45PM | Edited Transcript of BAX earnings conference call or presentation 31-Oct-18 12:30pm GMT Thomson Reuters StreetEvents |
10:46AM | 52-Week Company Lows GuruFocus.com |
08:15AM | Baxter Introduces New Tisseel Prima Syringe at 2018 American Association of Gynecologic Laparoscopists Meeting Business Wire |
Nov-06-18 04:15PM | Baxter to Present at Citis 2018 Global Healthcare Conference Business Wire |
Nov-05-18 10:33AM | 52-Week Company Lows GuruFocus.com |
Nov-02-18 12:03PM | Baxter International Breaks Its February/April Lows: Now What? TheStreet.com |
07:20AM | Report: Developing Opportunities within Pulse Biosciences, Baxter International, FirstEnergy, Affiliated Managers Group, Baidu, and Shopify Future Expectations, Projections Moving into 2018 GlobeNewswire |
Nov-01-18 09:53AM | Company News For Nov 1, 2018 Zacks |
Oct-31-18 06:28PM | Baxter Earnings beat, Revenue misses In Q3 Investing.com -8.96% |
02:23PM | Baxter International Inc (BAX) Q3 2018 Earnings Conference Call Transcript Motley Fool |
11:22AM | Baxter (BAX) Earnings Beat, Revenues Lag Estimates in Q3 Zacks |
11:06AM | Is Baxter International Incs (NYSE:BAX) 10% ROE Strong Compared To Its Industry? Simply Wall St. |
08:40AM | Baxter International (BAX) Tops Q3 Earnings Estimates Zacks |
07:35AM | Baxter: 3Q Earnings Snapshot Associated Press |
07:15AM | Baxter Reports Third-Quarter 2018 Results and Updates Financial Outlook for Full-Year 2018 Business Wire |
Oct-30-18 09:40AM | Medical Product Stock Q3 Earnings on Oct 31: BAX, MASI & More Zacks |
Oct-29-18 04:15PM | Baxter Highlights Clinical Data at ASN: Kidney Week Showing How New Technologies Are Advancing Dialysis Care across Modalities Business Wire |
07:00AM | Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies Business Wire |
Oct-25-18 08:15AM | Baxter Announces U.S. Regulatory Filing for PrisMax Acute Care System and Presentation of 15 Abstracts to Start ASN: Kidney Week 2018 Business Wire |
Oct-23-18 10:54AM | Can Medication Delivery Unit Aid Baxter's (BAX) Q3 Earnings? Zacks |
Oct-22-18 08:42AM | Medidata (MDSO) Tops Earnings & Revenue Estimates in Q3 Zacks |
Oct-19-18 09:30AM | Has Baxter International (BAX) Outpaced Other Medical Stocks This Year? Zacks |
09:30AM | BAX vs. BSX: Which Stock Should Value Investors Buy Now? Zacks |
09:29AM | Mallinckrodt (MNK) Gets $26 Million as Funding From BARDA Zacks |
08:05AM | Baxter to Showcase Critical Care Innovation at the 2018 European Society of Intensive Care Medicine Congress Business Wire |
Oct-17-18 11:57AM | Barclays Takes Action on Health Care Stocks GuruFocus.com |
Oct-16-18 10:47AM | What's in Store for Cerner (CERN) This Earnings Season? Zacks |
Oct-12-18 10:23AM | Cerner's Millennium Platform Integrated at McLaren Hospital Zacks |
10:10AM | Can Baxter (BAX) Keep the Earnings Surprise Streak Alive? Zacks |
Oct-11-18 09:20AM | Baxter & ASPEN Launch PN Tools to Boost Clinical Nutrition Zacks |
09:00AM | Investor Expectations to Drive Momentum within Materion, Iridium Communications, Natural Health Trends, Revance Therapeutics, Baxter International, and Alexion Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire |
Oct-10-18 08:00AM | Baxter and ASPEN Launch SmartPN Tools to Reinforce Appropriate Use of Parenteral Nutrition Business Wire |
Oct-07-18 05:20AM | Suvretta Capital Managements Return, AUM, and Holdings Insider Monkey |
Oct-05-18 09:58AM | Zacks.com highlights: Lululemon Athletica, Malibu Boats, Surmodics and Baxter International Zacks |
Oct-04-18 04:15PM | Baxter to Present at the 27th Annual Credit Suisse Healthcare Conference Business Wire |
10:28AM | Buy These 4 Efficient Stocks for Stellar Returns Zacks |
Oct-03-18 07:31AM | Baxter Collaborates With Mayo Clinic to Open Renal Care Center Zacks |
Oct-02-18 09:00AM | Baxter and Mayo Clinic Announce Collaboration to Establish Renal Care Center of Excellence in the U.S. Business Wire |
08:49AM | Baxter (BAX) Collaborates With USC CBC to Digitize Healthcare Zacks |
Sep-28-18 08:13AM | Baxter Collaborates with University of Southern California Center for Body Computing to Advance Digital Health Solutions Business Wire |
|
|
|
 |
Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. |
 |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
STALLKAMP THOMAS T | Director | Jan 18 | Sale | 70.00 | 3,187 | 223,090 | 9,418 | Jan 23 05:36 PM | FORSYTH JOHN D | Director | Dec 13 | Option Exercise | 24.27 | 1,500 | 36,405 | 31,640 | Dec 17 04:18 PM | Shapazian Carole J | Director | Dec 13 | Option Exercise | 39.83 | 4,110 | 163,701 | 13,958 | Dec 17 04:21 PM | Shapazian Carole J | Director | Dec 13 | Sale | 66.69 | 4,110 | 274,096 | 9,848 | Dec 17 04:21 PM | FORSYTH JOHN D | Director | Dec 13 | Sale | 67.02 | 1,500 | 100,530 | 30,140 | Dec 17 04:18 PM | Shapazian Carole J | Director | Dec 03 | Option Exercise | 41.23 | 11,749 | 484,408 | 21,597 | Dec 06 05:17 PM | Shapazian Carole J | Director | Dec 03 | Sale | 68.48 | 11,749 | 804,572 | 9,848 | Dec 06 05:17 PM | Third Point LLC | Director | Dec 03 | Sale | 68.62 | 8,000,000 | 548,960,000 | 28,008,125 | Dec 04 05:12 PM | Accogli Giuseppe | SVP, President, Global Bus. | Sep 17 | Option Exercise | 42.56 | 17,647 | 751,138 | 67,785 | Sep 19 05:42 PM | Eyre Brik V | SVP, President, Americas | Sep 17 | Option Exercise | 38.18 | 71,643 | 2,735,345 | 137,005 | Sep 19 05:43 PM | Eyre Brik V | SVP, President, Americas | Sep 17 | Sale | 77.31 | 78,012 | 6,031,108 | 58,993 | Sep 19 05:43 PM | Accogli Giuseppe | SVP, President, Global Bus. | Sep 17 | Sale | 77.27 | 17,647 | 1,363,584 | 50,138 | Sep 19 05:42 PM | Shapazian Carole J | Director | Aug 08 | Option Exercise | 37.50 | 5,400 | 202,500 | 15,248 | Aug 10 04:17 PM | Shapazian Carole J | Director | Aug 08 | Sale | 72.97 | 5,400 | 394,038 | 9,848 | Aug 10 04:17 PM | Pleau Scott | SVP, Operations | Jul 10 | Option Exercise | 48.13 | 10,686 | 514,364 | 30,899 | Jul 12 04:56 PM | Pleau Scott | SVP, Operations | Jul 10 | Sale | 75.00 | 10,686 | 801,450 | 20,213 | Jul 12 04:56 PM | Pleau Scott | SVP, Operations | Jun 25 | Option Exercise | 46.18 | 27,197 | 1,255,957 | 47,363 | Jun 27 05:26 PM | Pleau Scott | SVP, Operations | Jun 25 | Sale | 73.57 | 27,197 | 2,000,883 | 20,166 | Jun 27 05:26 PM | Shapazian Carole J | Director | May 22 | Option Exercise | 36.93 | 3,930 | 145,135 | 16,442 | May 23 05:33 PM | Eyre Brik V | SVP, President, Americas | May 22 | Option Exercise | 37.38 | 25,000 | 934,500 | 90,115 | May 23 05:45 PM | Eyre Brik V | SVP, President, Americas | May 22 | Sale | 71.96 | 25,000 | 1,799,000 | 65,115 | May 23 05:45 PM | Shapazian Carole J | Director | May 22 | Sale | 71.79 | 6,594 | 473,383 | 9,848 | May 23 05:33 PM | Mason Jeanne K | SVP, Human Resources | May 21 | Option Exercise | 28.27 | 31,395 | 887,537 | 128,777 | May 23 05:43 PM | Mason Jeanne K | SVP, Human Resources | May 21 | Sale | 72.00 | 31,395 | 2,260,440 | 97,382 | May 23 05:43 PM | Eyre Brik V | SVP, President, Americas | May 15 | Option Exercise | 37.38 | 20,000 | 747,600 | 85,115 | May 17 04:03 PM | Eyre Brik V | SVP, President, Americas | May 15 | Sale | 70.57 | 20,000 | 1,411,400 | 65,115 | May 17 04:03 PM | STROUCKEN ALBERT P L | Director | Apr 02 | Option Exercise | 33.77 | 3,760 | 126,975 | 28,380 | Apr 04 05:21 PM | HELLMAN PETER S | Director | Apr 02 | Option Exercise | 33.77 | 3,760 | 126,975 | 25,522 | Apr 04 05:21 PM | HELLMAN PETER S | Director | Apr 02 | Sale | 64.74 | 3,760 | 243,408 | 21,762 | Apr 04 05:21 PM | STROUCKEN ALBERT P L | Director | Apr 02 | Sale | 64.75 | 3,760 | 243,443 | 24,620 | Apr 04 05:21 PM | GAVIN JAMES R III | Director | Mar 28 | Option Exercise | 28.79 | 18,750 | 539,863 | 51,388 | Mar 30 04:03 PM | STORM KORNELIS J. | Director | Mar 28 | Option Exercise | 34.49 | 47,959 | 1,654,198 | 70,471 | Mar 30 04:05 PM | STORM KORNELIS J. | Director | Mar 28 | Sale | 64.64 | 47,959 | 3,100,114 | 22,512 | Mar 30 04:05 PM | GAVIN JAMES R III | Director | Mar 28 | Sale | 64.56 | 18,750 | 1,210,498 | 32,638 | Mar 30 04:03 PM | Shapazian Carole J | Director | Mar 02 | Option Exercise | 31.26 | 4,990 | 155,987 | 14,838 | Mar 05 04:06 PM | Shapazian Carole J | Director | Mar 02 | Sale | 66.05 | 4,990 | 329,590 | 9,848 | Mar 05 04:06 PM |
|
 |
|
 |
|